| Product Code: ETC6360673 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Parkinsons Disease Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Parkinsons Disease Market - Industry Life Cycle |
3.4 Belgium Parkinsons Disease Market - Porter's Five Forces |
3.5 Belgium Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Belgium Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Belgium Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Belgium Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Belgium Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Belgium Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Parkinson's disease among healthcare professionals and patients |
4.2.2 Technological advancements in treatment options for Parkinson's disease |
4.2.3 Growing elderly population in Belgium leading to higher prevalence of Parkinson's disease |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of new Parkinson's disease treatments |
4.3.2 Limited access to specialized healthcare services for Parkinson's patients in certain regions of Belgium |
4.3.3 High cost associated with Parkinson's disease medications and treatments |
5 Belgium Parkinsons Disease Market Trends |
6 Belgium Parkinsons Disease Market, By Types |
6.1 Belgium Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Belgium Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Belgium Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Belgium Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Belgium Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Belgium Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Belgium Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Belgium Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Belgium Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Belgium Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Belgium Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Belgium Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Belgium Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Belgium Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Belgium Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Belgium Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Belgium Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Belgium Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Belgium Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Belgium Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Belgium Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Belgium Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Belgium Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Belgium Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Belgium Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Belgium Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Belgium Parkinsons Disease Market Export to Major Countries |
7.2 Belgium Parkinsons Disease Market Imports from Major Countries |
8 Belgium Parkinsons Disease Market Key Performance Indicators |
8.1 Number of Parkinson's disease awareness campaigns conducted annually |
8.2 Adoption rate of new technologies in treating Parkinson's disease |
8.3 Percentage of elderly population diagnosed with Parkinson's disease |
8.4 Patient access to specialized Parkinson's disease healthcare services |
8.5 Average cost of Parkinson's disease medications and treatments for patients |
9 Belgium Parkinsons Disease Market - Opportunity Assessment |
9.1 Belgium Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Belgium Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Belgium Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Belgium Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Belgium Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Belgium Parkinsons Disease Market - Competitive Landscape |
10.1 Belgium Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Belgium Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here